Pre-Clinical Efficacy and Synergistic Potential of the MDM2-p53 Antagonists, Nutlin-3 and RG7388, as Single Agents and in Combined Treatment With Cisplatin in Ovarian Cancer

Oncotarget - United States
doi 10.18632/oncotarget.9499
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Synergistic Antitumor Effects of Combined Deguelin and Cisplatin Treatment in Gastric Cancer Cells

Oncology Letters
Cancer ResearchOncology
2014English

A P53-Independent Role for the MDM2 Antagonist Nutlin-3 in DNA Damage Response Initiation

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the P53-Reactivating Drugs Nutlin-3 and RITA

Cancer Research
Cancer ResearchOncology
2009English

Treatment Options in Recurrent Ovarian Cancer: Latest Evidence and Clinical Potential

Therapeutic Advances in Medical Oncology
Oncology
2014English

The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status

Haematologica
Hematology
2012English

Efficacy of Aidi Injection Combined With Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer

DEStech Transactions on Biology and Health
2018English

Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

ATM Dependent DUSP6 Modulation of P53 Involved in Synergistic Targeting of MAPK and P53 Pathways With Trametinib and MDM2 Inhibitors in Cutaneous Melanoma

Cancers
Cancer ResearchOncology
2018English

Synergistic Enhancement of Efficacy of Platinum Drugs With Verteporfin in Ovarian Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy